Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
Modeling probability of additional cases of natalizumab-associated JCV sero-negative progressive multifocal leukoencephalopathy.
Review of subcutaneous interferon β-1a, delivered via the electronic self-injection device RebiSmart™, for the treatment of multiple sclerosis.
Neuromyelitis Optica Following Human Papillomavirus Vaccination.
B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody.
Treatment of walking impairment in multiple sclerosis with dalfampridine.
Gilenya prescribing information
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.
Microvesicles: novel biomarkers for neurological disorders.
Tumefactive multiple sclerosis lesions under fingolimod treatment.
Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: protection by antioxidants.
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.
Treatment selection and experience in multiple sclerosis: survey of neurologists.
Molecular targets of FTY720 (fingolimod).
The effects of intrathecal rituximab on biomarkers in multiple sclerosis.
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Santhera enters agreement with Columbia University to investigate additional potential of Catena® in MELAS
A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis.
Leber's hereditary optic neuropathy associated with multiple sclerosis: Harding's syndrome.
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment.
Narcolepsy with cataplexy and comorbid immunopathological diseases.
Vitamin A and systemic inflammation as protective factors in multiple sclerosis.
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis.
The cost burden of multiple sclerosis in the United States: a systematic review of the literature.

Pages